Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

MGK vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, MGK returned +7.8% to XBI's +41.2%, and MGK charges 0.05% to XBI's 0.35%.

askIQ about this page

askIQ about MGK and XBI

Net assets: $34.9bn on Sep 30, 2026 for Vanguard Morningstar Mega Cap Growth ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+7.8%
MGK total return, 1 year
+41.2%
XBI total return, 1 year
0.05%
MGK expense ratio
0.35%
XBI expense ratio

Pair scorecard

MGK costs 0.30 points a year less; their one-year returns differ by 33.4 points; MGK is 3.4 times larger.

MGK vs XBI: Differences, Returns & Fees
MeasureMGKXBI
Return
Total return, 1 year+7.8%+41.2%
Drawdown
Below its high4.4%, high on Oct 6, 2026
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksMorningstar US Mega Cap Growth IndexBiotech
Cost and size
Expense ratio0.05%0.35%
Net assets, as of Sep 30, 2026$34.9bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common1%
Top ten holdings, share of the fund64.5%18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

1%

By the books each fund has filed, MGK and XBI hold 1% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

1% in common

Positions both hold · largest shared weight first MGK XBI
Vertex Pharmaceuticals Inc 0.61% 1.46%
Only in one fund ↓
Only in MGK
NVIDIA Corp 13.69%
Apple Inc 12.53%
Microsoft Corp 9.46%
Alphabet Inc 4.98%
Meta Platforms Inc 4.96%
Broadcom Inc 4.30%
Amazon.com Inc 4.22%
Alphabet Inc 3.95%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

MGK Vanguard Morningstar Mega Cap Growth ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of Mega Cap Growth Biotech
Total return, 1 year +7.8% +41.2%
Expense ratio 0.05% 0.35%
Already in the S&P 500 99.0% 13.2%
Holdings 54 165
Net assets, MGK as of Sep 30, 2026 and XBI as of Oct 27, 2026 $34.9bn $10.3bn

MGK and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
MGK

MGK tracks an index of Mega Cap Growth. Over the year to Oct 28, 2026 it returned +7.8% with distributions reinvested. The prospectus expense ratio is 0.05% a year. By its holdings published by its issuer as of Sep 30, 2026, 99% of the fund by weight is stocks the S&P 500 also holds, across 54 positions, with the top ten at 64.5%. It sat 4.4% below its high of Oct 6, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are MGK and XBI in the same category?
MGK is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, MGK or XBI?
In the year to Oct 28, 2026, with distributions reinvested, MGK returned +7.8% and XBI +41.2%.
Which is cheaper, MGK or XBI?
MGK is cheaper, by 0.30 percentage points a year. That is about $30 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do MGK and XBI overlap with the S&P 500?
By their latest filed holdings, 99% of MGK and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, MGK against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/mgk-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.